AI chatbot to guide thyroid cancer patients through perioperative education
Official title: Development and Application of an Artificial Intelligence Chatbot for Perioperative Health Education Among Thyroid Cancer Patients: A Quasi-Experimental Study
Run by Tianjin Medical University Cancer Institute and Hospital · NCT07634978 · Data updated 2026-11-12
A new AI chatbot is being tested to see if it helps thyroid cancer patients better prepare for discharge, recover well, and stay engaged in their care compared with traditional education.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Tianjin Medical University Cancer Institute and Hospital Academic / other |
| Locations | 1 site (Tianjin, Tianjin Municipality) |
| Status | Recruiting |
| Started | January 1, 2026 |
| Main results expected | August 1, 2026 |
| Study ends | August 31, 2026 |
| Registry record updated | June 9, 2026 |
| Trial ID | NCT07634978 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with thyroid cancer planned for elective surgery who can provide informed consent and will be able to interact with the chatbot.
✕Probably not a fit
Patients uncomfortable with digital tools or unable to access the chatbot may not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This non-randomized, sequential study compares standard perioperative education to education augmented by a Coze-based AI chatbot. The control phase uses routine nursing education, followed by an intervention phase where patients have 24/7 access to the chatbot for personalized guidance before and after surgery. Outcomes include readiness for discharge, quality of recovery, and patient engagement, along with usability feedback on the chatbot. The study is conducted at Tianjin Medical University Cancer Institute and Hospital with adults undergoing elective thyroid cancer surgery.
Why it matters
Potential benefit: If successful, the chatbot could enhance perioperative education and support, potentially shortening recovery time and increasing patient engagement.
How similar studies have gone: Prior digital health education tools have shown feasibility; this study tests a dedicated AI chatbot in the perioperative thyroid cancer setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with thyroid cancer in accordance with the clinical diagnostic criteria, and confirmed by ultrasonography and histopathological examination. * Scheduled to undergo elective surgery for thyroid cancer. * Mentally competent to understand the study protocol, and voluntarily provided written informed consent to participate in this study. Exclusion Criteria: * Aged less than 18 years. * Concurrently diagnosed with malignant tumors in other organs or severe complications/dysfunctions of other major organs. * Patients who are anticipated to be unable to complete the study protocol due to plans for hospital/department transfer, or high risk of treatment discontinuation.
Where it's running
-
Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality, China Recruiting
Study contacts
- Study coordinator: jiayan Cao
- Email: Caojiayan_1976@126.com
- Phone: 86+23340123-3130
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
MRG003 added to ongoing treatment after progression in EGFR-positive advanced thyroid cancer
In this study, researchers test whether adding MRG003 to a patient’s current thyroid cancer treatment can shrink tumors for those whose cancer initially responded but later progressed.
-
Selective coverage radiotherapy vs. full coverage radiotherapy for poorly differentiated and anaplastic thyroid cancer
This trial tests whether covering only the tumor-affected area with radiation is as effective as full-area coverage radiotherapy for poorly differentiated and anaplastic thyroid cancer, while aiming to reduce side effects and improve quality of life.
-
Trop-2 Targeted PET/CT for Recurrent and Metastatic Thyroid Cancer
This study tests whether a Trop-2 targeted PET/CT scan can better detect recurrent or metastatic thyroid cancer in adults than another PET/CT scan (FAPI).
-
WeChat-supported neck exercises after thyroidectomy
A telehealth program using a WeChat mini program tests if guided neck exercises after thyroid surgery help early recovery and quality of life.
-
Pralsetinib Drug Interaction Study in RET Fusion/MUTATION Positive Solid Tumors
This trial tests whether pralsetinib changes how the body processes certain medicines in adults with RET fusion- or mutation-positive advanced solid tumors.
-
Bilateral neck block during thyroid surgery to see if stress markers change
Researchers will test whether adding a bilateral intermediate cervical plexus block to the anesthesia during total thyroidectomy helps reduce the surgical stress response in adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.